Pharmacokinetics of Aliskiren in Patients with End-Stage Renal Disease Undergoing Haemodialysis

被引：0
|
作者：
Dmytro Khadzhynov
Torsten Slowinski
Ina Lieker
Hans-Hellmut Neumayer
Diego Albrecht
Henk Johan Streefkerk
Sam Rebello
Harm Peters
机构：
[1] Charité Universitätsmedizin Berlin,Department of Nephrology
[2] Humboldt University,Novartis Institutes for Biomedical Research
[3] Translational Science,undefined
来源：
Clinical Pharmacokinetics | 2012年 / 51卷
关键词：
Ezetimibe; Aliskiren; ESRD Patient; Eprosartan; Haemodialysis Session;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：661 / 669
页数：8
相关论文
共 50 条
  • [21] Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis
    Bain, MA
    Faull, R
    Fornasini, G
    Milne, RW
    Evans, AM
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (05) : 1300 - 1304
  • [22] Changes of Left and Right Ventricle Mechanics and Function in Patients with End-Stage Renal Disease Undergoing Haemodialysis
    Tarnulenaite, Egle
    Zvirblyte, Ruta
    Ereminiene, Rata
    Ziginskiene, Edita
    Ereminiene, Egle
    [J]. MEDICINA-LITHUANIA, 2018, 54 (05):
  • [23] Prediction of pharmacokinetics of antibiotics in patients with end-stage renal disease
    Tajima, Naoyuki
    Nagashima, Satoru
    Uematsu, Toshihiko
    Torii, Hideki
    Tajima, Masami
    Hishida, Akira
    Naganuma, Hideo
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2006, 29 (07) : 1454 - 1459
  • [24] Pharmacokinetics of Intravenous Delafloxacin in Patients With End-Stage Renal Disease
    Hoover, Randall
    Alcorn, Harry, Jr.
    Lawrence, Laura
    Paulson, Susan K.
    Quintas, Megan
    Cammarata, Sue K.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (07): : 913 - 919
  • [25] Indinavir pharmacokinetics in haemodialysis-dependent end-stage renal failure
    Guardiola, JM
    Mangues, MA
    Domingo, P
    Martínez, E
    Barrio, JL
    [J]. AIDS, 1998, 12 (11) : 1395 - 1395
  • [26] Pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessions
    Leuppi-Taegtmeyer, Anne
    Duthaler, Urs
    Hammann, Felix
    Schmid, Yasmin
    Dickenmann, Michael
    Amico, Patricia
    Jehle, Andreas W.
    Kalbermatter, Stefan
    Lenherr, Christoph
    Schwabedissen, Henriette E. Meyer Zu
    Haschke, Manuel
    Liechti, Matthias E.
    Krahenbuhl, Stephan
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (04) : 692 - 702
  • [27] Immunodiagnosis and molecular validation of Toxoplasma gondii infection among patients with end-stage renal disease undergoing haemodialysis
    Arab-Mazar, Zahra
    Fallahi, Shirzad
    Yadegarynia, Davood
    Mamaghani, Amirreza Javadi
    Tabaei, Seyyed Javad Seyyed
    Rajaeian, Simin
    Roodsari, Sara Rahmati
    [J]. PARASITOLOGY, 2019, 146 (13) : 1683 - 1689
  • [28] Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis (vol 113, pg 719, 2015)
    不详
    [J]. THROMBOSIS AND HAEMOSTASIS, 2017, 117 (04) : 821 - 821
  • [29] Pulmonary hypertension in end-stage renal disease patients undergoing haemodialysis via arterio-venous access
    Amin, A.
    Chitsazan, M.
    Navid, H.
    Chitsazan, M.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 317 - 317
  • [30] Effect of fludrocortisone acetate on reducing serum potassium levels in patients with end-stage renal disease undergoing haemodialysis
    Kim, Dong-Min
    Chung, Jong Hoon
    Yoon, Sung Ho
    Kim, Hyun Lee
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (11) : 3273 - 3276
12345